Illumina is a prominent entity in the genomic sequencing market, providing advanced DNA sequencing platforms and associated ...
Hosted on MSN1mon
Illumina launches compact, low-cost gene sequencing devicesNew generation sequencers, like Illumina's MiSeq devices, help determine the sequence of DNA or RNA to study genetic variation associated with diseases and diagnose rare genetic conditions.
Illumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific ...
Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...
Illumina's margin expansion and a coming revenue recovery should help the stock multiples re-rate toward life science ...
Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting: San Diego Monday, November 4, 2024, 17:0 ...
Designed to make next-generation sequencing accessible to more labs SAN DIEGO, Oct. 24, 2024 /PRNewswire/ -- Illumina, Inc.
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will present updates on several key innovations in whole-genome sequencing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback